Mazumdar-Shaw Kiran bought BCAX
June 9, 2026 · Form 4 insider transaction
Mazumdar-Shaw Kiran bought 19,475 shares of Bicara Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
19,475
Price
$0.00
Total value
N/A
InsiderMazumdar-Shaw Kiran
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 9, 2026
Filing dateJune 10, 2026
Shares owned after19,475
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1. The shares underlying this stock option vest upon the earlier of (i) June 9, 2027 or (ii) the date of the next Annual Meeting of Stockholders of Bicara Therapeutics Inc., subject to the Reporting Person's continued service on such vesting date.